Insights
Catastrophic Claims Often Require Nuanced Solutions
November 3, 2021
In workers’ compensation, catastrophic injuries transpire with relatively low frequency.
FDA Approves Combination NSAID/Opioid Seglentis
October 22, 2021
2 MIN READOn October 18, 2021, Seglentis was approved by the U.S. Food and Drug Administration (FDA).
FDA Approves Combination NSAID/Opioid Seglentis
October 21, 2021
2 MIN READOn October 18, 2021, Seglentis was approved by the U.S. Food and Drug Administration (FDA). Seglentis contains tramadol, a short-acting opioid, and celecoxib, a non-steroidal anti-inflammatory drug (NSAID), and is indicated for adults in the management of acute pain that is severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
Specialty Services Are a Big Deal
October 21, 2021
When adjusters have to jump through hoops to make referrals, they lose precious time. When it comes to specialty services, we have your back.
Navigating Michigan’s No-Fault Auto Fee Schedule Four Months In
On-Demand
In this upcoming webinar, hear the latest from Enlyte experts on Michigan’s no-fault fee schedule, including product info and regulatory changes.
2021 mPower Virtual Conference
On-Demand
The Mitchell | Genex | Coventry team looks forward to connecting with you at the 2021 mPower Conference, taking place virtually October 12–14, 2021.
From Permanent Disability to Full-Duty Success
October 11, 2021
2 MIN READDisability Case Management Meet Nancy LeBlanc, RN, CCM, CPDM, WES
Technology and Expertise Driving Better Claims Outcomes
Mitchell simplifies and accelerates claims management and collision repair processes through the broadest range of technology solutions, networks, and partners in the P&C industry.
Learn MoreHelping Injured Workers Get Better, Faster.
Genex helps injured employees return to their jobs in a safe and efficient manner through compassionate case management while reducing total claim cost.
Learn More